Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 21 | 20 | −1 |
| Shares | 7.61M | 7.54M | −75.0K (−1.0%) |
| Value | $40.1M | $23.3M | −$16.8M (−41.9%) |
New holders (2)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 64 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Bailard, Inc. | 21,200 | $110.0K |
| Veritable, L.P. | 20,534 | $110.0K |
| Morgan Stanley | 5 | $0 |